ITCI logo

Intra-Cellular Therapies (ITCI) Accounts Receivable

ITCI Annual Accounts Receivable

$114.02 M
+$38.83 M+51.64%

31 December 2023

ITCI Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ITCI Quarterly Accounts Receivable

$145.61 M
-$106.00 K-0.07%

30 September 2024

ITCI Quarterly Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ITCI Accounts Receivable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+51.6%+41.8%
3 y3 years+959.2%+41.8%
5 y5 years-+41.8%

ITCI Accounts Receivable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+465.7%-0.1%+622.4%
5 y5-yearat high-0.1%
alltimeall timeat high-0.1%

Intra-Cellular Therapies Accounts Receivable History

DateAnnualQuarterly
Sept 2024
-
$145.61 M(-0.1%)
June 2024
-
$145.71 M(+11.1%)
Mar 2024
-
$131.16 M(+15.0%)
Dec 2023
$114.02 M(+51.6%)
$114.02 M(+11.1%)
Sept 2023
-
$102.67 M(+7.0%)
June 2023
-
$95.96 M(+17.7%)
Mar 2023
-
$81.55 M(+8.5%)
Dec 2022
$75.19 M(+273.0%)
$75.19 M(+22.2%)
Sept 2022
-
$61.54 M(+31.0%)
June 2022
-
$46.98 M(+43.1%)
Mar 2022
-
$32.83 M(+62.9%)
Dec 2021
$20.16 M(+87.2%)
$20.16 M(+19.0%)
Sept 2021
-
$16.93 M(+11.5%)
June 2021
-
$15.19 M(+11.2%)
Mar 2021
-
$13.66 M(+26.9%)
Dec 2020
$10.76 M
$10.76 M(+43.9%)
Sept 2020
-
$7.48 M(+217.9%)
June 2020
-
$2.35 M(+74.2%)
DateAnnualQuarterly
Mar 2020
-
$1.35 M(>+9900.0%)
Dec 2019
$0.00(-100.0%)
$0.00(-100.0%)
Sept 2017
-
$6300.00(-89.8%)
June 2017
-
$61.90 K(-9.2%)
Mar 2017
-
$68.20 K(-27.7%)
Dec 2016
$94.30 K(+207.2%)
$94.30 K(+7153.8%)
Sept 2016
-
$1300.00(-98.7%)
June 2016
-
$98.20 K(+219.9%)
Dec 2015
$30.70 K(-40.5%)
$30.70 K(>+9900.0%)
Sept 2015
-
$0.00(-100.0%)
June 2015
-
$9100.00(+175.8%)
Mar 2015
-
$3300.00(-93.6%)
Dec 2014
$51.60 K(-84.7%)
$51.60 K(-58.5%)
Sept 2014
-
$124.40 K(-43.2%)
June 2014
-
$219.20 K(+30.6%)
Mar 2014
-
$167.80 K(-50.1%)
Dec 2013
$336.30 K
$336.30 K(+33.8%)
Sept 2013
-
$251.30 K

FAQ

  • What is Intra-Cellular Therapies annual accounts receivable?
  • What is the all time high annual accounts receivable for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies annual accounts receivable year-on-year change?
  • What is Intra-Cellular Therapies quarterly accounts receivable?
  • What is the all time high quarterly accounts receivable for Intra-Cellular Therapies?
  • What is Intra-Cellular Therapies quarterly accounts receivable year-on-year change?

What is Intra-Cellular Therapies annual accounts receivable?

The current annual accounts receivable of ITCI is $114.02 M

What is the all time high annual accounts receivable for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high annual accounts receivable is $114.02 M

What is Intra-Cellular Therapies annual accounts receivable year-on-year change?

Over the past year, ITCI annual accounts receivable has changed by +$38.83 M (+51.64%)

What is Intra-Cellular Therapies quarterly accounts receivable?

The current quarterly accounts receivable of ITCI is $145.61 M

What is the all time high quarterly accounts receivable for Intra-Cellular Therapies?

Intra-Cellular Therapies all-time high quarterly accounts receivable is $145.71 M

What is Intra-Cellular Therapies quarterly accounts receivable year-on-year change?

Over the past year, ITCI quarterly accounts receivable has changed by +$42.94 M (+41.82%)